SELLAS Life Sciences (SLS) Leases (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Leases for 6 consecutive years, with $513000.0 as the latest value for Q3 2024.
- On a quarterly basis, Leases fell 13.34% to $513000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $513000.0, a 13.34% decrease, with the full-year FY2023 number at $858000.0, down 1.83% from a year prior.
- Leases was $513000.0 for Q3 2024 at SELLAS Life Sciences, down from $633000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $1.1 million in Q1 2022 to a low of $123000.0 in Q1 2020.
- A 5-year average of $784736.8 and a median of $812000.0 in 2021 define the central range for Leases.
- Peak YoY movement for Leases: tumbled 73.89% in 2020, then skyrocketed 594.31% in 2021.
- SELLAS Life Sciences' Leases stood at $896000.0 in 2020, then fell by 19.31% to $723000.0 in 2021, then rose by 20.89% to $874000.0 in 2022, then decreased by 1.83% to $858000.0 in 2023, then tumbled by 40.21% to $513000.0 in 2024.
- Per Business Quant, the three most recent readings for SLS's Leases are $513000.0 (Q3 2024), $633000.0 (Q2 2024), and $747000.0 (Q1 2024).